MA3 is expressed in 76% of metastatic melanomas [27], in up to 50% of nonsmall cell lung cancer [29], and in many other tumor types such as colon rectal, hepatocyte cellular, prostate and breast cancers, and haematological malignancies such as multiple myeloma [30, 33–36]. Here, PNMA3 is linked to neoplasm.